U.S. panel to review heart inflammation cases after Pfizer, Moderna vaccines

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are set to meet on Wednesday to assess the possibility of a link between rare cases of heart inflammation and the mRNA COVID-19 vaccines from Pfizer and partner BioNTech and from Moderna.